Open AccessEvaluating the effect of a Russian rituximab biosimilar used to treat patients with rheumatoid arthritis on healthcare budgets
Author(s) -
Р. О. Древаль
Publication year - 2018
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2018-2-58-63
Subject(s) - biosimilar , rheumatoid arthritis , rituximab , reimbursement , subsidy , medicine , health care , russian federation , business , economic growth , economics , economic policy , market economy , lymphoma